Jefferies Financial Group Inc. Bridge Bio Pharma, Inc. Transaction History

Jefferies Financial Group Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$27.35 - $40.45 $1.14 Million - $1.69 Million	-41,840 Reduced 40.33%	61,907 $1.91 Million
Q4 2023 Feb 13, 2024	BUY	$24.02 - $43.89 $1.07 Million - $1.96 Million	44,558 Added 75.28%	103,747 $4.19 Million
Q3 2023 Nov 14, 2023	SELL	$16.89 - $35.01 $3.6 Million - $7.46 Million	-213,049 Reduced 78.26%	59,189 $1.56 Million
Q2 2023 Aug 14, 2023	BUY	$13.29 - $18.01 $1.49 Million - $2.01 Million	111,868 Added 69.76%	272,238 $4.68 Million
Q1 2023 May 15, 2023	BUY	$7.17 - $18.55 $1.15 Million - $2.97 Million	160,370 New	160,370 $2.66 Million

291

171M

10.4M

2.37M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.42B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

Stay updated on Jefferies Financial Group Inc. with notifications on news.